Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2025-12-25 @ 10:24 PM
Study NCT ID:
NCT01367158
Status:
COMPLETED
Last Update Posted:
2014-11-19
First Post:
2011-06-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines
Sponsor:
Novartis Vaccines
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-03
First Submit QC Date:
None
Study First Post Date:
2011-06-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-02-11
Results First Submit QC Date:
None
Results First Post Date:
2014-11-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-17
Last Update Post Date:
2014-11-19
Last Update Post Date Type:
ESTIMATED